ANALYSIS OF MHC CLASS-I AND CLASS-II EXPRESSION IN RELATION TO PRESENCE OF HPV GENOTYPES IN PREMALIGNANT AND MALIGNANT CERVICAL LESIONS

被引:112
作者
CROMME, FV
MEIJER, CJLM
SNIJDERS, PJF
UYTERLINDE, A
KENEMANS, P
HELMERHORST, T
STERN, PL
VANDENBRULE, AJC
WALBOOMERS, JMM
机构
[1] FREE UNIV AMSTERDAM HOSP, INST PATHOL, MOLEC PATHOL SECT, DE BOELELAAN 1117, 1081 HV AMSTERDAM, NETHERLANDS
[2] CHRISTIE HOSP & HOLT RADIUM INST, NHS TRUST, PATERSON INST CANC RES, MANCHESTER M20 9BX, LANCS, ENGLAND
[3] FREE UNIV AMSTERDAM HOSP, DEPT GYNAECOL, 1081 HV AMSTERDAM, NETHERLANDS
关键词
D O I
10.1038/bjc.1993.254
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cervical intraepithelial neoplasia (CIN) grades I to III lesions (n = 94) and squamous cell carcinomas of the uterine cervix (n = 27) were analysed for MHC class I and II expression and presence of HPV genotypes. MHC class I and II expression was studied by immunohistochemistry and HPV typing was performed by general primer- and type-specific primer mediated PCR (GP/TS PCR). Both techniques were performed on paraffin embedded tissue sections. Results show disturbed MHC class I heavy chain expression in CIN I to CIN III, as well as in cervical carcinomas. Upregulated MHC class 11 expression on dysplastic epithelial cells was also found in the different CIN groups and carcinomas. Prevalence of HPV genotypes increased with the severity of the lesion, mainly due to the contribution of the HPV types 16 and 18. No correlation could be established between the presence of specific HPV genotypes and any MHC expression pattern in the different CIN groups or cervical carcinomas. In some cases these data were confirmed by RNA in situ hybridisation showing HPV 16 E7 transcripts in the same dysplastic/neoplastic cells from which MHC status was determined. The results indicate that local differences may exist in the type of cellular immune response to HPV induced lesions.
引用
收藏
页码:1372 / 1380
页数:9
相关论文
共 35 条
[1]   ABERRANT EXPRESSION OF HLA CLASS-I ANTIGENS IN BURKITT-LYMPHOMA CELLS [J].
ANDERSSON, ML ;
STAM, NJ ;
KLEIN, G ;
PLOEGH, HL ;
MASUCCI, MG .
INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (04) :544-550
[2]   PHENOTYPIC DYNAMICS OF TUMOR PROGRESSION IN HUMAN-MALIGNANT MELANOMA [J].
BROCKER, EB ;
SUTER, L ;
BRUGGEN, J ;
RUITER, DJ ;
MACHER, E ;
SORG, C .
INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (01) :29-35
[3]   LOSS OF MHC CLASS-I EXPRESSION IN CERVICAL CARCINOMAS [J].
CONNOR, ME ;
STERN, PL .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (06) :1029-1034
[4]   MARKEDLY DECREASED EXPRESSION OF CLASS-I HISTOCOMPATIBILITY ANTIGENS, PROTEIN, AND MESSENGER-RNA IN HUMAN SMALL-CELL LUNG-CANCER [J].
DOYLE, A ;
MARTIN, WJ ;
FUNA, K ;
GAZDAR, A ;
CARNEY, D ;
MARTIN, SE ;
LINNOILA, I ;
CUTTITTA, F ;
MULSHINE, J ;
BUNN, P ;
MINNA, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) :1135-1151
[5]  
DURST M, 1987, ONCOGENE, V1, P251
[6]   HLA-DR EXPRESSION IS ASSOCIATED WITH EXCELLENT PROGNOSIS IN SQUAMOUS-CELL CARCINOMA OF THE LARYNX [J].
ESTEBAN, F ;
RUIZCABELLO, F ;
CONCHA, A ;
PEREZAYALA, M ;
SANCHEZROZAS, JA ;
GARRIDO, F .
CLINICAL & EXPERIMENTAL METASTASIS, 1990, 8 (04) :319-328
[7]   EXPRESSION OF MHC PRODUCTS AND LEUKOCYTE DIFFERENTIATION ANTIGENS IN GYNECOLOGICAL NEOPLASMS - AN IMMUNOHISTOLOGICAL ANALYSIS OF THE TUMOR-CELLS AND INFILTRATING LEUKOCYTES [J].
FERGUSON, A ;
MOORE, M ;
FOX, H .
BRITISH JOURNAL OF CANCER, 1985, 52 (04) :551-563
[8]   DISTRIBUTION OF HLA CLASS-1 ANTIGENS IN NORMAL HUMAN-TISSUE AND IN MAMMARY-CANCER [J].
FLEMING, KA ;
MCMICHAEL, A ;
MORTON, JA ;
WOODS, J ;
MCGEE, JO .
JOURNAL OF CLINICAL PATHOLOGY, 1981, 34 (07) :779-784
[9]  
GAARENSTROOM KN, 1992, UNPUB
[10]  
GLEW SS, 1992, CANCER RES, V52, P4009